Genes and cigarette smoking

Addiction

Volumn 103, Issue 6, 2008, Pages 893-904

  Munafò, Marcus R ^a   Johnstone, Elaine C ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cigarette smoking; Genetics; Heritability; Tobacco addiction

Indexed keywords

BEHAVIOR; CHROMOSOME; CIGARETTE SMOKING; GENE IDENTIFICATION; GENE LOCUS; GENETIC LINKAGE; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HERITABILITY; HUMAN; LINKAGE ANALYSIS; MOLECULAR GENETICS; NEUROIMAGING; PHENOTYPE; RELIABILITY; REVIEW; RISK FACTOR; SMOKING CESSATION; SMOKING HABIT; TOBACCO DEPENDENCE; TWINS;

AGE OF ONSET; BEHAVIOR, ADDICTIVE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE (GENETICS); NEEDS ASSESSMENT; PHENOTYPE; RESEARCH; SMOKING; TWIN STUDIES AS TOPIC;

EID: 44149120764     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2007.02071.x     Document Type: Review

References (103)

1. Doll R., Peto R., Boreham J., Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004 328 : 1519.
2. Munafo M. R., Shields A. E., Berrettini W. H., Patterson F., Lerman C. Pharmacogenetics and nicotine addiction treatment. Pharmacogenomics 2005 6 : 211 23.
3. Hopper J. A., Gallagher R. E. Tobacco cessation: new challenges, new opportunities. J Cancer Educ 2003 18 : 128 33.
4. Carmelli D., Swan G. E., Robinette D., Fabsitz R. Genetic influence on smoking - a study of male twins. N Engl J Med 1992 327 : 829 33.
5. Heath A. C., Cates R., Martin N. G., Meyer J., Hewitt J. K., Neale M. C. et al. Genetic contribution to risk of smoking initiation: comparisons across birth cohorts and across cultures. J Subst Abuse 1993 5 : 221 46.
6. Heath A. C., Martin N. G. Genetic models for the natural history of smoking: evidence for a genetic influence on smoking persistence. Addict Behav 1993 18 : 19 34.
7. Heath A. C., Madden P. A., Slutske W. S., Martin N. G. Personality and the inheritance of smoking behavior: a genetic perspective. Behav Genet 1995 25 : 103 17.
8. Kendler K. S., Neale M. C., Sullivan P., Corey L. A., Gardner C. O., Prescott C. A. A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med 1999 29 : 299 308.
9. True W. R., Heath A. C., Scherrer J. F., Waterman B., Goldberg J., Lin N. et al. Genetic and environmental contributions to smoking. Addiction 1997 92 : 1277 87.
10. Sullivan P. F., Kendler K. S. The genetic epidemiology of smoking. Nicotine Tob Res 1999 1 : S51 7 discussion S69 70.
11. Niu T., Chen C., Ni J., Wang B., Fang Z., Shao H. et al. Nicotine dependence and its familial aggregation in Chinese. Int J Epidemiol 2000 29 : 248 52.
12. Xian H., Scherrer J. F., Madden P. A., Lyons M. J., Tsuang M., True W. R. et al. The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit. Nicotine Tob Res 2003 5 : 245 54.
13. Pergadia M. L., Heath A. C., Martin N. G., Madden P. A. Genetic analyses of DSM-IV nicotine withdrawal in adult twins. Psychol Med 2006 36 : 963 72.
14. Munafo M. R., Clark T., Johnstone E., Murphy M., Walton R. The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob Res 2004 6 : 583 97.
15. Pomerleau O. F. Individual differences in sensitivity to nicotine: implications for genetic research on nicotine dependence. Behav Genet 1995 25 : 161 77.
16. Nestler E. J. Genes and addiction. Nat Genet 2000 26 : 277 81.
17. Munafo M. R., Flint J. Meta-analysis of genetic association studies. Trends Genet 2004 20 : 439 44.
18. Menzel S. Genetic and molecular analyses of complex metabolic disorders: genetic linkage. Ann NY Acad Sci 2002 967 : 249 57.
19. Bergen A. W., Korczak J. F., Weissbecker K. A., Goldstein A. M. A genome-wide search for loci contributing to smoking and alcoholism. Genet Epidemiol 1999 17 : S55 60.
20. Bierut L. J., Rice J. P., Goate A., Hinrichs A. L., Saccone N. L., Foroud T. et al. A genomic scan for habitual smoking in families of alcoholics: common and specific genetic factors in substance dependence. Am J Med Genet A 2004 124 : 19 27.
21. Gelernter J., Liu X., Hesselbrock V., Page G. P., Goddard A., Zhang H. Results of a genomewide linkage scan: support for chromosomes 9 and 11 loci increasing risk for cigarette smoking. Am J Med Genet B Neuropsychiatr Genet 2004 128 : 94 101.
22. Vink J. M., Beem A. L., Posthuma D., Neale M. C., Willemsen G., Kendler K. S. et al. Linkage analysis of smoking initiation and quantity in Dutch sibling pairs. Pharmacogenomics J 2004 4 : 274 82.
23. Straub R. E., Sullivan P. F., Ma Y., Myakishev M. V., Harris-Kerr C., Wormley B. et al. Susceptibility genes for nicotine dependence: a genome scan and followup in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit further study. Mol Psychiatry 1999 4 : 129 44.
24. Sullivan P. F., Neale B. M., van den Oord E., Miles M. F., Neale M. C., Bulik C. M. et al. Candidate genes for nicotine dependence via linkage, epistasis, and bioinformatics. Am J Med Genet B Neuropsychiatr Genet 2004 126 : 23 36.
25. Goode E. L., Badzioch M. D., Kim H., Gagnon F., Rozek L. S., Edwards K. L. et al. Multiple genome-wide analyses of smoking behavior in the Framingham Heart Study. BMC Genet 2003 4 : S102.
26. Stallings M. C., Corley R. P., Hewitt J. K., Krauter K. S., Lessem J. M., Mikulich S. K. et al. A genome-wide search for quantitative trait loci influencing substance dependence vulnerability in adolescence. Drug Alcohol Depend 2003 70 : 295 307.
27. Li M. D., Ma J. Z., Cheng R., Dupont R. T., Williams N. J., Crews K. M. et al. A genome-wide scan to identify loci for smoking rate in the Framingham Heart Study population. BMC Genet 2003 4 : S103.
28. Beuten J., Ma J. Z., Payne T. J., Dupont R. T., Lou X. Y., Crews K. M. et al. Association of specific haplotypes of neurotrophic tyrosine kinase receptor 2 gene (NTRK2) with vulnerability to nicotine dependence in African-Americans and European-Americans. Biol Psychiatry 2007 61 : 48 55.
29. Beuten J., Ma J. Z., Payne T. J., Dupont R. T., Crews K. M., Somes G. et al. Single- and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. Am J Hum Genet 2005 76 : 859 64.
30. Xu C., Goodz S., Sellers E. M., Tyndale R. F. CYP2A6 genetic variation and potential consequences. Adv Drug Deliv Rev 2002 54 : 1245 56.
31. Malaiyandi V., Sellers E. M., Tyndale R. F. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clin Pharmacol Ther 2005 77 : 145 58.
32. Saarikoski S. T., Sata F., Husgafvel-Pursiainen K., Rautalahti M., Haukka J., Impivaara O. et al. CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behaviour. Pharmacogenetics 2000 10 : 5 10.
33. Feng Y., Niu T., Xing H., Xu X., Chen C., Peng S. et al. A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. Am J Hum Genet 2004 75 : 112 21.
34. Li M. D., Beuten J., Ma J. Z., Payne T. J., Lou X. Y., Garcia V. et al. Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum Mol Genet 2005 14 : 1211 19.
35. De Luca V., Wang H., Squassina A., Wong G. W., Yeomans J., Kennedy J. L. Linkage of M5 muscarinic and alpha7-nicotinic receptor genes on 15q13 to schizophrenia. Neuropsychobiology 2004 50 : 124 7.
36. Saccone S. F., Hinrichs A. L., Saccone N. L., Chase G. A., Konvicka K., Madden P. A. et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 2007 16 : 36 49.
37. Jonsson E. G., Nothen M. M., Grunhage F., Farde L., Nakashima Y., Propping P. et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 1999 4 : 290 6.
38. Neville M. J., Johnstone E. C., Walton R. T. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 2004 23 : 540 5.
39. Gelernter J. Yu Y., Weiss R., Brady K., Panhuysen C., Yang B. Z. et al. Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet 2006 15 : 3498 507.
40. Yoshida K., Hamajima N., Kozaki K., Saito H., Maeno K., Sugiura T. et al. Association between the dopamine D2 receptor A2/A2 genotype and smoking behavior in the Japanese. Cancer Epidemiol Biomarkers Prev 2001 10 : 403 5.
41. Laucht M., Becker K., El-Faddagh M., Hohm E., Schmidt M. H. Association of the DRD4 exon III polymorphism with smoking in fifteen-year-olds: a mediating role for novelty seeking? J Am Acad Child Adolesc Psychiatry 2005 44 : 477 84.
42. Sullivan P. F., Neale M. C., Silverman M. A., Harris-Kerr C., Myakishev M. V., Wormley B. et al. An association study of DRD5 with smoking initiation and progression to nicotine dependence. Am J Med Genet 2001 105 : 259 65.
43. Jorm A. F., Henderson A. S., Jacomb P. A., Christensen H., Korten A. E., Rodgers B. et al. Association of smoking and personality with a polymorphism of the dopamine transporter gene: results from a community survey. Am J Med Genet 2000 96 : 331 4.
44. Olsson C., Anney R., Forrest S., Patton G., Coffey C., Cameron T. et al. Association between dependent smoking and a polymorphism in the tyrosine hydroxylase gene in a prospective population-based study of adolescent health. Behav Genet 2004 34 : 85 91.
45. Freire M. T., Marques F. Z., Hutz M. H., Bau C. H. Polymorphisms in the DBH and DRD2 gene regions and smoking behavior. Eur Arch Psychiatry Clin Neurosci 2006 256 : 93 7.
46. Zhang H. Ye Y., Wang X., Gelernter J., Ma J. Z., Li M. D. DOPA decarboxylase gene is associated with nicotine dependence. Pharmacogenomics 2006 7 : 1159 66.
47. Ma J. Z., Beuten J., Payne T. J., Dupont R. T., Elston R. C., Li M. D. Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence. Hum Mol Genet 2005 14 : 1691 8.
48. Yu Y., Panhuysen C., Kranzler H. R., Hesselbrock V., Rounsaville B., Weiss R. et al. Intronic variants in the dopa decarboxylase (DDC) gene are associated with smoking behavior in European-Americans and African-Americans. Hum Mol Genet 2006 15 : 2192 9.
49. Guo S., Chen D. F., Zhou D. F., Sun H. Q., Wu G. Y., Haile C. N. et al. Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers. Psychopharmacology (Berl) 2007 190 : 449 56.
50. Beuten J., Payne T. J., Ma J. Z., Li M. D. Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. Neuropsychopharmacology 2006 31 : 675 84.
51. Trummer O., Koppel H., Wascher T. C., Grunbacher G., Gutjahr M., Stanger O. et al. The serotonin transporter gene polymorphism is not associated with smoking behavior. Pharmacogenomics J 2006 6 : 397 400.
52. Jin Y., Chen D., Hu Y., Guo S., Sun H., Lu A. et al. Association between monoamine oxidase gene polymorphisms and smoking behaviour in Chinese males. Int J Neuropsychopharmacol 2006 9 : 557 64.
53. Picciotto M. R., Corrigall W. A. Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. J Neurosci 2002 22 : 3338 41.
54. Comings D. E., Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res 2000 126 : 325 41.
55. Bierut L. J., Madden P. A., Breslau N., Johnson E. O., Hatsukami D., Pomerleau O. F. et al. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet 2007 16 : 24 35.
56. Liu Y., Yoshimura K., Hanaoka T., Ohnami S., Ohnami S., Kohno T. et al. Association of habitual smoking and drinking with single nucleotide polymorphism (SNP) in 40 candidate genes: data from random population-based Japanese samples. J Hum Genet 2005 50 : 62 8.
57. Epperson C. N., O'Malley S., Czarkowski K. A., Gueorguieva R., Jatlow P., Sanacora G. et al. Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy. Biol Psychiatry 2005 57 : 44 8.
58. Uhl G. R., Liu Q. R., Drgon T., Johnson C., Walther D., Rose J. E. Molecular genetics of nicotine dependence and abstinence: whole genome association using 520 0 00 SNPs. BMC Genet 2007 8 : 10.
59. Audrain-McGovern J., Rodriguez D., Tercyak K. P., Cuevas J., Rodgers K., Patterson F. Identifying and characterizing adolescent smoking trajectories. Cancer Epidemiol Biomark Prev 2004 13 : 2023 34.
60. Lerman C., Wileyto E. P., Patterson F., Rukstalis M., Audrain-McGovern J., Restine S. et al. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Pharmacogenomics J 2004 4 : 184 92.
61. Wileyto E. P., Patterson F., Niaura R., Epstein L. H., Brown R. A., Audrain-McGovern J. et al. Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion. Nicotine Tob Res 2005 7 : 257 68.
62. Flint J., Munafo M. R. The endophenotype concept in psychiatric genetics. Psychol Med 2007 37 : 163 80.
63. Hutchison K. E., Niaura R., Swift R. The effects of smoking high nicotine cigarettes on prepulse inhibition, startle latency, and subjective responses. Psychopharmacology (Berl) 2000 150 : 244 52.
64. Blendy J. A., Strasser A., Walters C. L., Perkins K. A., Patterson F., Berkowitz R. et al. Reduced nicotine reward in obesity: cross-comparison in human and mouse. Psychopharmacology (Berl) 2005 180 : 306 15.
65. Tiffany S. T., Cox L. S., Elash C. A. Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers. J Consult Clin Psychol 2000 68 : 233 40.
66. Munafo M. R., Mogg K., Roberts S., Bradley B. P., Murphy M. Selective processing of smoking-related cues in current smokers, ex-smokers and never-smokers on the modified Stroop task. J Psychopharmacol 2003 17 : 310 16.
67. Waters A. J., Shiffman S., Bradley B. P., Mogg K. Attentional shifts to smoking cues in smokers. Addiction 2003 98 : 1409 17.
68. Ray R., Schnoll R. A., Lerman C. Pharmacogenetics and smoking cessation with nicotine replacement therapy. CNS Drugs 2007 21 : 525 33.
69. Munafo M. R., Johnstone E. C., Mackintosh B. Association of serotonin transporter genotype with selective processing of smoking-related stimuli in current smokers and ex-smokers. Nicotine Tob Res 2005 7 : 773 8.
70. Hariri A. R., Weinberger D. R. Imaging genomics. Br Med Bull 2003 65 : 259 70.
71. Meyer-Lindenberg A., Weinberger D. R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 2006 7 : 818 27.
72. David S. P., Munafo M. R., Johansen-Berg H., Smith S. M., Rogers R. D., Matthews P. M. et al. Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biol Psychiatry 2005 58 : 488 94.
73. Due D. L., Huettel S. A., Hall W. G., Rubin D. C. Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am J Psychiatry 2002 159 : 954 60.
74. Brody A. L., Mandelkern M. A., Lee G., Smith E., Sadeghi M., Saxena S. et al. Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study. Psychiatry Res 2004 130 : 269 81.
75. Brody A. L., Mandelkern M. A., Olmstead R. E., Scheibal D., Hahn E., Shiraga S. et al. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry 2006 63 : 808 16.
76. Xu J., Mendrek A., Cohen M. S., Monterosso J., Rodriguez P., Simon S. L. et al. Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence. Biol Psychiatry 2005 58 : 143 50.
77. Xu J., Mendrek A., Cohen M. S., Monterosso J., Simon S., Jarvik M. et al. Effect of cigarette smoking on prefrontal cortical function in nondeprived smokers performing the Stroop task. Neuropsychopharmacology 2007 32 : 1421 8.
78. Moffitt T. E., Caspi A., Rutter M. Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry 2005 62 : 473 81.
79. Lerman C., Jepson C., Wileyto E. P., Epstein L. H., Rukstalis M., Patterson F. et al. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology 2006 31 : 231 42.
80. Munafo M. R., Johnstone E. C., Wileyto E. P., Shields P. G., Elliot K. M., Lerman C. Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomark Prev 2006 15 : 398 400.
81. Munafo M. R., Elliot K. M., Murphy M. F., Walton R. T., Johnstone E. C. Association of the mu-opioid receptor gene with smoking cessation. Pharmacogenomics J 2007 7 : 353 61.
82. Munafo M. R., Murphy M. F., Johnstone E. C. Smoking cessation, weight gain, and DRD4-521 genotype. Am J Med Genet B Neuropsychiatr Genet 2006 141 : 398 402.
83. Johnstone E. C., Yudkin P. L., Hey K., Roberts S. J., Welch S. J., Murphy M. F. et al. Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Pharmacogenetics 2004 14 : 83 90.
84. Yudkin P., Munafo M., Hey K., Roberts S., Welch S., Johnstone E. et al. Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial. BMJ 2004 328 : 989 90.
85. Lerman C., Shields P. G., Wileyto E. P., Audrain J., Pinto A., Hawk L. et al. Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics 2002 12 : 627 34.
86. Lerman C., Shields P. G., Wileyto E. P., Audrain J., Hawk L. H., Jr., Pinto A. et al. Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Health Psychol 2003 22 : 541 8.
87. Dahl J. P., Jepson C., Levenson R., Wileyto E. P., Patterson F., Berrettini W. H. et al. Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence. Pharmacogenomics J 2006 6 : 194 9.
88. David S. P., Brown R. A., Papandonatos G. D., Kahler C. W., Lloyd-Richardson E. E., Munafo M. R. et al. Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine Tob Res 2007 9 : 821 33.
89. Swan G. E., Valdes A. M., Ring H. Z., Khroyan T. V., Jack L. M., Ton C. C. et al. Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR. Pharmacogenomics J 2005 5 : 21 9.
90. Cinciripini P., Wetter D., Tomlinson G., Tsoh J., De Moor C., Cinciripini L. et al. The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood. Nicotine Tob Res 2004 6 : 229 39.
91. Boyadjieva N. I., Sarkar D. K. The secretory response of hypothalamic beta-endorphin neurons to acute and chronic nicotine treatments and following nicotine withdrawal. Life Sci 1997 61 : PL59 66.
92. Robinson T. E., Berridge K. C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993 18 : 247 91.
93. Malaiyandi V., Lerman C., Benowitz N. L., Jepson C., Patterson F., Tyndale R. F. Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Mol Psychiatry 2006 11 : 400 9.
94. Lee A. M., Jepson C., Hoffmann E., Epstein L., Hawk L. W., Lerman C. et al. CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial. Biol Psychiatry 2007 62 : 635 41.
95. Berrettini W. H., Wileyto E. P., Epstein L., Restine S., Hawk L., Shields P. et al. Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. Biol Psychiatry 2007 61 : 111 18.
96. Welton N. J., Johnstone E. C., David S. P., Munafo M. R. A cost-effectiveness analysis of genetic testing to aid treatment choice for smoking cessation. Nicotine Tob Res 2008 in press.
97. Yang I. A., Savarimuthu S., Kim S. T., Holloway J. W., Bell S. C., Fong K. M. Gene-environmental interaction in asthma. Curr Opin Allergy Clin Immunol 2007 7 : 75 82.
98. Kraft P., Hunter D. Integrating epidemiology and genetic association: the challenge of gene-environment interaction. Phil Trans R Soc Lond B Biol Sci 2005 360 : 1609 16.
99. Wang W. Y., Barratt B. J., Clayton D. G., Todd J. A. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005 6 : 109 18.
100. Sham P., Bader J. S., Craig I., O'Donovan M., Owen M. DNA pooling: a tool for large-scale association studies. Nat Rev Genet 2002 3 : 862 71.
101. Merikangas K. R., Risch N. Genomic priorities and public health. Science 2003 302 : 599 601.
102. Gilpin E. A., Emery S. L., Farkas A. J., Distefan J. M., White M. M., Pierce J. P. The California Tobacco Control Program. A Decade of Progress, Results from the California Tobacco Survey, 1990-1999. La Jolla, CA : University of California, San Diego 2001.
103. Warner K. E., Burns D. M. Hardening and the hard-core smoker: concepts, evidence, and implications. Nicotine Tob Res 2003 5 : 37 48.